Cernostics Raises $2.5 Million in Series A1 Financing, Led by Illumina Ventures
– TissueCypher® Barrett’s Esophagus Assay is First Precision Medicine Platform for Prevention of Esophageal Cancer – PITTSBURGH, Penn., March 21 2018 — Cernostics, a privately-held company focused on delivering next-generation cance...
Read more
